ADRs End Slightly Higher; Teva, Ryanair, SAP Trade Actively
January 11 2018 - 6:00PM
Dow Jones News
International stocks trading in New York closed slightly higher
on Thursday.
The BNY Mellon index of American depositary receipts rose 0.7%
to 159.62. The European index increased 0.6% to 146.49. The Asian
index increased 0.5% to 191.62. The Latin American index increased
1.8% to 263.77. And the emerging-markets index rose 0.6% to
343.88.
Teva Pharmaceutical Industries Ltd. (TEVA), Ryanair Holdings Plc
(RYAAY), and SAP SE (SAP) were among those with ADRs that traded
actively.
Israeli pharmaceutical company Teva has begun settlement talks
with Ohio concerning the state's lawsuit alleging illegal marketing
of opioid painkillers, according to the state's attorney general.
The state is also engaged in talks with Johnson & Johnson. Ohio
was one of the first states to sue opioid-painkiller makers,
alleging they fueled the opioid-addiction crisis by misrepresenting
the benefits and addictive risks of their painkillers. The
companies have denied the allegations and said they are committed
to the safe and medically appropriate use of the drugs. ADRs of
Teva rose 8.5% to $21.74.
Ireland-based Ryanair's stock was upgraded by UBS to buy from
neutral because of positive consumer sentiment and the likelihood
of Ryanair returning about 22% of its market capitalization to
shareholders over the next three years. The Swiss bank also says
that although Ryanair's costs are increasing, it believes the
budget airline will continue to have the lowest cost per unit
compared with peers Wizz Air and easyJet. ADRs of Ryanair rose 3.2%
to $112.82.
Consensus forecasts suggest Germany-based SAP's cloud and
software businesses should deliver at least 8% revenue growth in
2018, a figure Morgan Stanley analysts deem "at the high end of
what is reasonable." Since such consensus expectations are above
the upper end of SAP's initial guidance in both 2016 and 2017, the
analysts lower the German company's rating to equalweight from
overweight and cut its target price to EUR105 from EUR111. Morgan
Stanley adds that SAP's margins aren't likely to expand in a
significant way until 2019. ADRs of SAP dropped 2.9% to
$109.64.
Write to Aisha Al-Muslim at aisha.al-muslim@wsj.com
(END) Dow Jones Newswires
January 11, 2018 17:45 ET (22:45 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
Teva Pharmaceutical Indu... (NYSE:TEVA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Teva Pharmaceutical Indu... (NYSE:TEVA)
Historical Stock Chart
From Sep 2023 to Sep 2024